News | January 28, 2022
Lupin signs promotional agreement with Exeltis on SOLOSEC
SOLOSEC is designed to be easy to take and one oral dose contains a complete course of treatment
SOLOSEC is designed to be easy to take and one oral dose contains a complete course of treatment
Entos will receive an initial payment of US $50 million, which includes an equity investment by Lilly
The company will collaborate with U.S.-based colleagues to help life sciences companies improve commercial effectiveness
The multi-target agreement covers five programmes focused on off-the-shelf vaccines for cancer and infectious disease
The Ahmedabad based hospital in association with Sankalp India Foundation had established the BMT unit in 2017
New safety data show a consistent benefit-risk profile across all Ocrevus clinical trials
Cadila's ZyCov-D (DNA-based vaccine) is undergoing phase III trials.
AdCOVID is a COVID-19 vaccine candidate that is administered via nasal spray.
The request stemmed from a 2024 lawsuit by Rampart alleging Egg Medical had infringed its patent
NewCo’s pipeline includes five investigational medicines
Subscribe To Our Newsletter & Stay Updated
